Complement Inhibition in Severe COVID-19 Acute Respiratory Distress Syndrome
Pediatrics
[키워드] Acute kidney injury
acute lung injury
acute respiratory distress
acute respiratory distress syndrome (ARDS)
AKI
animal model
ARDS
Asymptomatic
children
children with COVID-19
complement
convalescent plasma
COVID - 19
COVID-19
Critically ill
Deterioration
died
disease
eculizumab
Immune-mediated
inflammatory pathways
inhibition
lung
Lung function
lung tissue
mild illness
MOST
patients with COVID-19
pediatric
respiratory
SARS-CoV
SARS-CoV-2
supported
syndrome
treated
with COVID-19
[DOI] 10.3389/fped.2020.616731 PMC 바로가기 [Article Type] Pediatrics
[DOI] 10.3389/fped.2020.616731 PMC 바로가기 [Article Type] Pediatrics